{
    "clinical_study": {
        "@rank": "73901", 
        "acronym": "IRLC", 
        "arm_group": [
            {
                "arm_group_label": "Lung cancer", 
                "description": "Patients with histologically confirmed non small cell lung cancer"
            }, 
            {
                "arm_group_label": "Control", 
                "description": "Patients without lung cancer or other malignancies"
            }
        ], 
        "biospec_descr": {
            "textblock": "Blood serum and lung biopsy"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "This study is designed to evaluate the importance of the immune cells localization\n      (distribution) between malignant tumor islets and surrounding stroma and to investigate the\n      associations between these immune cells as well as cytokines and clinicopathological and\n      prognostic factors of non-small cell lung cancer (NSCLC) patients."
        }, 
        "brief_title": "Immune Response in Lung Cancer", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Lung Cancer", 
        "condition_browse": {
            "mesh_term": "Lung Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Eastern Cooperative Oncology Group (ECOG) score of 0-1 Patients with histologically\n        documented non-small cell lung cancer Control group - patients without non-small cell lung\n        cancer Written (signed) Informed Consent to participate in the study\n\n        Exclusion Criteria:\n\n        Any other malignancies within 5 years Any unstable systemic disease (including active\n        infections, significant cardiovascular disease) Prior chemotherapy or radiotherapy\n        Autoimmune disease Nursing or pregnant women"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Lithuanian residents who are investigated ant treated in Hospital of Lithuanian University\n        of Health Sciences Kaunas Clinics Department of Pulmonology and Immunology  and Department\n        of Heart, thoracic and vascular surgery"
            }
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01955343", 
            "org_study_id": "IRLC-1109"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Immune response", 
            "Cancer"
        ], 
        "lastchanged_date": "September 27, 2013", 
        "location": {
            "contact": {
                "email": "rektoratas@lsmuni.lt", 
                "last_name": "Remigijus Zaliunas, Professor", 
                "phone": "+37037327200"
            }, 
            "facility": {
                "address": {
                    "city": "Kaunas", 
                    "country": "Lithuania", 
                    "zip": "LT 44307"
                }, 
                "name": "Lithuanian University of Health Sciences"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Lithuania"
        }, 
        "number_of_groups": "2", 
        "official_title": "Immune Response in Lung Cancer", 
        "overall_contact": {
            "email": "marius.zemaitis@kaunoklinikos.lt", 
            "last_name": "Marius Zemaitis, Assoc.Prof.", 
            "phone": "+37061256473"
        }, 
        "overall_contact_backup": {
            "email": "jjackute@gmail.com", 
            "last_name": "Jurgita Jackute, PhD", 
            "phone": "+37068216024"
        }, 
        "overall_official": {
            "affiliation": "Lithuanian University of Health Sciences", 
            "last_name": "Marius Zemaitis, Assoc.Prof.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Lithuania: Bioethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "progression-free survival", 
            "safety_issue": "No", 
            "time_frame": "one year after enrolment to the study"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01955343"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Lithuanian University of Health Sciences", 
            "investigator_full_name": "Marius Zemaitis", 
            "investigator_title": "Assoc. Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Lithuanian University of Health Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Lithuanian University of Health Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }
}